Please be patient! It may take up to ONE minute to load all the Engines.
Problems? Please contact our support.
Fetal-maternal erythrocyte distribution
Alternative namesThe fetal-maternal erythrocyte distribution test is used to measure the number of fetal red blood cells in a pregnant woman's blood. (See also Rh incompatibility .)
How the test is performed
Blood is drawn from a vein ( venipuncture ), usually from the inside of the elbow or the back of the hand. The puncture site is cleaned with antiseptic, and a tourniquet (an elastic band) or blood pressure cuff is placed around the upper arm to apply pressure and restrict blood flow through the vein. This causes veins below the tourniquet to distend (fill with blood). A needle is inserted into the vein, and the blood is collected in an air-tight vial or a syringe. During the procedure, the tourniquet is removed to restore circulation. Once the blood has been collected, the needle is removed, and the puncture site is covered to stop any bleeding .
The sample is taken to the laboratory where the hemoglobin is removed and both fetal and maternal red blood cells are counted. Based on that count a ratio of fetal to maternal blood cells is determined.
How to prepare for the testNo special preparation is necessary for this test.
How the test will feel
When the needle is inserted to draw blood, some people feel moderate pain, while others feel only a prick or stinging sensation. Afterward, there may be some throbbing.
Why the test is performed
Some red blood cells from the fetus are transferred into the mother's bloodstream during a miscarriage, abortion , amniocentesis , or normal delivery. If a large number of red blood cells are transferred to an from an Rh-positive fetus to an Rh-negative mother, Rh sensitization may occur. If the mother is Rh negative and the fetus is Rh positive, the mother's body may produce antibodies against the fetal cells, and this could harm her next child during pregnancy.
This test determines the amount of maternal-fetal blood exchange, and estimates the quantity of RhoGAM that should be administered. RhoGAM will attack the fetal cells in the maternal bloodstream and prevent maternal formation of anti-Rh antibodies that could endanger future pregnancies.
A normal value indicates that no or few fetal cells are present in the maternal blood. The standard dose of RhoGAM is sufficient in this case.
What abnormal results mean
An increased fetal-maternal red blood cell ratio indicates a need for additional RhoGAM.
What the risks areRisks associated with venipuncture are slight:
Update Date: 11/18/2002Daniel Rein, M.D., University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network.
Last updated: Tue, 06 Jan 2009 00:20:03 GMT